Skip Navigation

Exhibit 300 (BY2009) - PHIN: BioSense, Centers for Disease Control and Prevention

PART ONE


OVERVIEW


1. Date of Submission:
2008-02-04
2. Agency:
009
3. Bureau:
20
4. Name of this Capital Asset:
CDC PHIN: BioSense
5. Unique Project Identifier:
009-20-01-03-01-1163-00
6. What kind of investment will this be in FY2009?
Mixed Life Cycle
7. What was the first budget year this investment was submitted to OMB?
FY2004
8. Provide a brief summary and justification for this investment, including a brief description of how this closes in part or in whole an identified agency performance gap.
BioSense is a national program intended to improve the nation's capabilities for conducting near real-time biosurveillance and health situational awareness through access to existing data from healthcare organizations across the country and national data sources. BioSense is developing and implementing enhanced capabilities for early event detection and real-time health situational awareness. The objective is to expedite event recognition and response coordination among federal, state, and local public health and healthcare organizations by providing each level of public health access to the same data, at the same time. BioSense receives, analyzes, and evaluates health data from national data sources including DoD and VA hospitals and ambulatory care clinics, and a large commercial clinical laboratory. In addition, local hospitals, healthcare systems, and syndromic surveillance systems transmit real-time clinical data to BioSense. Public health uses BioSense data in many ways; to monitor disease trends in their communities, to track potential disease cases, and to incorporate with other local surveillance efforts. In 2005, the program's recruitment goal was to have one hospital from 10 different cities transmitting real-time data to BioSense. This goal was achieved. In 2006, the program's recruitment goal is to have 350 hospitals transmitting real-time data to BioSense. This goal was achieved. 2007 goals include continuing to build BioSense as a network of networks. BioSense supports four of CDC's Preparedness goals: decrease the time needed to classify health events as terrorism or naturally occurring, improve the timeliness and accuracy of communications regarding threats to the public's health, decrease the time to identify causes, risk factors, and appropriate interventions for those affected by threats to the public's health, and decrease the time needed to provide countermeasures and health guidance to those affected by threats to the public's health.
9. Did the Agency's Executive/Investment Committee approve this request?
yes
9.a. If "yes," what was the date of this approval?
2007-06-26
10. Did the Project Manager review this Exhibit?
yes
11.a. What is the current FAC-P/PM certification level of the project/program manager?
Senior/Expert-level
12. Has the agency developed and/or promoted cost effective, energy-efficient and environmentally sustainable techniques or practices for this project.
yes
12.a. Will this investment include electronic assets (including computers)?
yes
12.b. Is this investment for new construction or major retrofit of a Federal building or facility? (answer applicable to non-IT assets only)
no
13. Does this investment directly support one of the PMA initiatives?
yes
If yes, select the initiatives that apply:
Initiative Name
Expanded E-Government
13.a. Briefly and specifically describe for each selected how this asset directly supports the identified initiative(s)? (e.g. If E-Gov is selected, is it an approved shared service provider or the managing partner?)
BioSense was architected to provide states and local health departments a national repository for visualizing situational awareness thus creating a single point of access to Biosurveillance aggregated data. Prior to BioSense, situational awareness had no national representation, so to create awareness was a manual effort for the public and government entities that own the data. The system allows mapping of progressing syndromes to be communicated via electronic media.
14. Does this investment support a program assessed using the Program Assessment Rating Tool (PART)?
yes
14.a. If yes, does this investment address a weakness found during the PART review?
yes
14.b. If yes, what is the name of the PARTed program?
2006: CDC - Terrorism: Biosurveillance
14.c. If yes, what rating did the PART receive?
Results Not Demostrated
15. Is this investment for information technology?
yes
16. What is the level of the IT Project (per CIO Council's PM Guidance)?
Level 3
17. What project management qualifications does the Project Manager have? (per CIO Council's PM Guidance)
(1) Project manager has been validated as qualified for this investment
18. Is this investment identified as high risk on the Q4 - FY 2007 agency high risk report (per OMB memorandum M-05-23)?
yes
19. Is this a financial management system?
no
20. What is the percentage breakout for the total FY2009 funding request for the following? (This should total 100%)
AreaPercentage
Hardware0
Software0
Services100
Other0
21. If this project produces information dissemination products for the public, are these products published to the Internet in conformance with OMB Memorandum 05-04 and included in your agency inventory, schedules and priorities?
no
22. Contact information of individual responsible for privacy related questions.
NameAlice M. Brown
Phone Number770-488-8223
TitleIT Security Project Manager
EmailAMBrown1@cdc.gov
23. Are the records produced by this investment appropriately scheduled with the National Archives and Records Administration's approval?
yes
24. Does this investment directly support one of the GAO High Risk Areas?
no

SUMMARY OF SPEND


1. Provide the total estimated life-cycle cost for this investment by completing the following table. All amounts represent budget authority in millions, and are rounded to three decimal places. Federal personnel costs should be included only in the row designated Government FTE Cost, and should be excluded from the amounts shown for Planning, Full Acquisition, and Operation/Maintenance. The total estimated annual cost of the investment is the sum of costs for Planning, Full Acquisition, and Operation/Maintenance. For Federal buildings and facilities, life-cycle costs should include long term energy, environmental, decommissioning, and/or restoration costs. The costs associated with the entire life-cycle of the investment should be included in this report.

All amounts represent Budget Authority

Note: For the cross-agency investments, this table should include all funding (both managing partner and partner agencies).

Government FTE Costs should not be included as part of the TOTAL represented.
Cost TypePy-1 & Earlier
-2006
PY
2007
CY
2008
BY
2009
Planning Budgetary Resources0.3000.0000.0000.000
Acquisition Budgetary Resources104.21029.44019.80528.300
Maintenance Budgetary Resources2.4402.4402.4002.400
Government FTE Cost5.2504.8206.0006.000
# of FTEs17454545
2. Will this project require the agency to hire additional FTE's?
yes
2.a. If "yes," how many and in what year?
In 2006 this investment had 17 FTEs, an additional 13 have been hired bringing the total to 30 as of 08/20/07. Leadership believes the current need for the remainder of '07 and early '08 is to hire an additional 15-16 FTEs bringing the total up to 45. The Summary of Spending indicated 45 FTE positions by the end of 2007 and through 2013. The BioSense leadership believes this staffing level will yield the highest return on investment and allow for efficient development and operations.
3. If the summary of spending has changed from the FY2008 President's budget request, briefly explain those changes.
The extramural amount for BioSense is as a result of the new ceiling letter. Extramural dollars are reflected in another entry in Part V of the Exhibit 53.

PERFORMANCE


In order to successfully address this area of the exhibit 300, performance goals must be provided for the agency and be linked to the annual performance plan. The investment must discuss the agency's mission and strategic goals, and performance measures (indicators) must be provided. These goals need to map to the gap in the agency's strategic goals and objectives this investment is designed to fill. They are the internal and external performance benefits this investment is expected to deliver to the agency (e.g., improve efficiency by 60 percent, increase citizen participation by 300 percent a year to achieve an overall citizen participation rate of 75 percent by FY 2xxx, etc.). The goals must be clearly measurable investment outcomes, and if applicable, investment outputs. They do not include the completion date of the module, milestones, or investment, or general goals, such as, significant, better, improved that do not have a quantitative measure.
Agencies must use the following table to report performance goals and measures for the major investment and use the Federal Enterprise Architecture (FEA) Performance Reference Model (PRM). Map all Measurement Indicators to the corresponding Measurement Area and Measurement Grouping identified in the PRM. There should be at least one Measurement Indicator for each of the four different Measurement Areas (for each fiscal year). The PRM is available at www.egov.gov. The table can be extended to include performance measures for years beyond FY 2009.
RowFiscal YearStrategic Goal SupportedMeasurement AreaMeasurement GroupingMeasurement IndicatorBaselinePlanned Improvement to the BaselineActual Results
12006S.O. 2.4 - Prepare for and respond to natural and man-made disastersMission and Business ResultsPopulation Health Management and Consumer Safety# of health interactions in key jurisdictions related to the early detection and quantification of possible bioterrorism events.30,143,598 recordsIncrease by 10% over the previous year's volume the number of health interactions related to the early detection and quantification of possible bioterrorism events that are made available for analysis to local, state, federal public health agenciesAs of April 2006: Achieved more than 20% over the previous year's volume
22006S.O. 2.4 - Prepare for and respond to natural and man-made disastersCustomer ResultsNew Customers and Market Penetration% of state and local Public Health Department's serviced in key jurisdictionsTBD33% of State and local public health agencies in key jurisdictions have access to BioSense dataMarch 2007: 124 public health jurisdictions had access to BioSense data
32006S.O. 2.4 - Prepare for and respond to natural and man-made disastersTechnologyExternal Data Sharing# of data sources7 data sourcesCDC acquires sources from 8 potential data sourcesSept 2006: 46 real time data sources and 466 DoD and 863 VA healthcare facilities sending data to BioSense
42006S.O. 2.4 - Prepare for and respond to natural and man-made disastersProcesses and ActivitiesCycle TimeTime required to update BioSense dataData completeness varies by Source from 2-4 daysBioSense data is updated within 24 hours of receipt from data providersSept 2006: Average 2.81 hours from "Time of Visit" to "Viewable in BioSense application" for real time data sources
52007S.O. 2.4 - Prepare for and respond to natural and man-made disastersProcesses and ActivitiesCycle TimeTime required to update BioSense data2.81 hours from "Time of Visit" to "Viewable in BioSense application"No more than 2 hours from "Time of Visit" to "Viewable in BioSense application"In progress
62007S.O. 2.4 - Prepare for and respond to natural and man-made disastersMission and Business ResultsPopulation Health Management and Consumer Safety# of health interactions in key jurisdictions related to early detection and quantification of possible bioterrorism events.36 million recordsIncrease by 10% over the previous year's volume the number of health interactions related to the early detection and quantification of possible bioterrorism events that are made available for analysis to local, state, federal public health agenciesIn progress
72007S.O. 2.4 - Prepare for and respond to natural and man-made disastersCustomer ResultsNew Customers and Market Penetration% of eligible customer services50% of State and local public health agencies in key jurisdictions have to access BioSense data75% of State and local public health agencies in key jurisdictions have to access BioSense dataJuly 2007: 137 public health jurisdictions had access to BioSense data.
82007S.O. 2.4 - Prepare for and respond to natural and man-made disastersTechnologyExternal Data Sharing# of data sources11 data sources and 39 hospitals sending foundational dataCDC acquires sources from 60 potential data sources and 1100 hospitalsAug 2007: 357 real time data sources, 466 DoD and 863 VA healthcare facilities and 2 special data sources sending data to BioSense
92008S.O. 2.4 - Prepare for and respond to natural and man-made disastersMission and Business ResultsPopulation Health Management and Consumer Safety# of health interactions in key jurisdictions related to the early detection and quantification of possible bioterrorism events.TBDIncrease by 10% over the previous year's volume the number of health interactions related to the early detection and quantification of possible bioterrorism events that are made available for analysis to local, state, federal public health agenciesTBD
102008S.O. 2.4 - Prepare for and respond to natural and man-made disastersCustomer ResultsNew Customers and Market Penetration% of state and local Public Health Department's serviced in key jurisdictionsTBD60% of State and local public health agencies in key jurisdictions have to access BioSense dataTBD
112008S.O. 2.4 - Prepare for and respond to natural and man-made disastersTechnologyExternal Data Sharing# of data sourcesTBDCDC acquires sources from 100 potential data sources and 1100 hospitalsTBD
122008S.O. 2.4 - Prepare for and respond to natural and man-made disastersProcesses and ActivitiesCycle TimeTime required to update BioSense dataTBDNo more than 2 hours from "Time of Visit" to "Viewable in BioSense applicationTBD
132009S.O. 2.4 - Prepare for and respond to natural and man-made disastersMission and Business ResultsPopulation Health Management and Consumer Safety# of health interactions in key jurisdictions related to the early detection and quantification of possible bioterrorism events.TBDIncrease by 10% over the previous year's volume the number of health interactions related to the early detection and quantification of possible bioterrorism events that are made available for analysis to local, state, federal public health agenciesTBD
142009S.O. 2.4 - Prepare for and respond to natural and man-made disastersCustomer ResultsNew Customers and Market Penetration% of state and local Public Health Department's serviced in key jurisdictionsTBD85% of State and local public health agencies in key jurisdictions have to access BioSense dataTBD
152009S.O. 2.4 - Prepare for and respond to natural and man-made disastersTechnologyExternal Data Sharing# of data sourcesTBDCDC acquires sources from 200 potential data sources and 3200 hospitalsTBD
162009S.O. 2.4 - Prepare for and respond to natural and man-made disastersProcesses and ActivitiesCycle TimeTime required to update BioSense dataTBDNo more than 2 hours from "Time of Visit" to "Viewable in BioSense applicationTBD
172010S.O. 2.4 - Prepare for and respond to natural and man-made disastersMission and Business ResultsPopulation Health Management and Consumer Safety# of health interactions in key jurisdictions related to the early detection and quantification of possible bioterrorism events.TBDIncrease by 10% over the previous year's volume the number of health interactions related to the early detection and quantification of possible bioterrorism events that are made available for analysis to local, state, federal public health agenciesTBD
182010S.O. 2.4 - Prepare for and respond to natural and man-made disastersCustomer ResultsNew Customers and Market Penetration% of state and local Public Health Department's serviced in key jurisdictionsTBD88% of State and local public health agencies in key jurisdictions have to access BioSense dataTBD
192010S.O. 2.4 - Prepare for and respond to natural and man-made disastersTechnologyExternal Data Sharing# of data sourcesTBDCDC acquires sources from 50 potential data sources andTBD
202010S.O. 2.4 - Prepare for and respond to natural and man-made disastersProcesses and ActivitiesCycle TimeTime required to update BioSense dataTBDNo more than 2 hours from "Time of Visit" to "Viewable in BioSense applicationTBD
212011S.O. 2.4 - Prepare for and respond to natural and man-made disastersMission and Business ResultsPopulation Health Management and Consumer Safety# of health interactions in key jurisdictions related to the early detection and quantification of possible bioterrorism events.TBDIncrease by 10% over the previous year's volume the number of health interactions related to the early detection and quantification of possible bioterrorism events that are made available for analysis to local, state, federal public health agenciesTBD
222011S.O. 2.4 - Prepare for and respond to natural and man-made disastersCustomer ResultsNew Customers and Market Penetration% of state and local Public Health Department's serviced in key jurisdictionsTBD88% of State and local public health agencies in key jurisdictions have to access BioSense dataTBD
232011S.O. 2.4 - Prepare for and respond to natural and man-made disastersTechnologyExternal Data Sharing# of data sourcesTBDCDC acquires sources from 18 potential data sourcesTBD
242011S.O. 2.4 - Prepare for and respond to natural and man-made disastersProcesses and ActivitiesCycle TimeTime required to update BioSense dataTBDNo more than 2 hours from "Time of Visit" to "Viewable in BioSense applicationTBD
252012S.O. 2.4 - Prepare for and respond to natural and man-made disastersMission and Business ResultsPopulation Health Management and Consumer Safety# of health interactions in key jurisdictions related to the early detection and quantification of possible bioterrorism events.TBDIncrease by 10% over the previous year's volume the number of health interactions related to the early detection and quantification of possible bioterrorism events that are made available for analysis to local, state, federal public health agenciesTBD
262012S.O. 2.4 - Prepare for and respond to natural and man-made disastersCustomer ResultsNew Customers and Market Penetration% of state and local Public Health Department's serviced in key jurisdictionsTBD88% of State and local public health agencies in key jurisdictions have to access BioSense dataTBD
272012S.O. 2.4 - Prepare for and respond to natural and man-made disastersTechnologyExternal Data Sharing# of data sourcesTBDCDC acquires sources from 22 potential data sourcesTBD
282012S.O. 2.4 - Prepare for and respond to natural and man-made disastersProcesses and ActivitiesCycle TimeTime required to update BioSense dataTBDNo more than 2 hours from "Time of Visit" to "Viewable in BioSense applicationTBD
292013S.O. 2.4 - Prepare for and respond to natural and man-made disastersMission and Business ResultsPopulation Health Management and Consumer Safety# of health interactions in key jurisdictions related to the early detection and quantification of possible bioterrorism events.TBDTBD 
302013S.O. 2.4 - Prepare for and respond to natural and man-made disastersCustomer ResultsNew Customers and Market Penetration% of state and local Public Health Department's serviced in key jurisdictionsTBDTBD 
312013S.O. 2.4 - Prepare for and respond to natural and man-made disastersTechnologyExternal Data Sharing# of data sourcesTBDTBD 
322013S.O. 2.4 - Prepare for and respond to natural and man-made disastersProcesses and ActivitiesCycle TimeTime required to update BioSense dataTBDTBD 

Enterprise Architecture


In order to successfully address this area of the business case and capital asset plan you must ensure the investment is included in the agency's EA and Capital Planning and Investment Control (CPIC) process, and is mapped to and supports the FEA. You must also ensure the business case demonstrates the relationship between the investment and the business, performance, data, services, application, and technology layers of the agency's EA.
1. Is this investment included in your agency's target enterprise architecture?
yes
2. Is this investment included in the agency's EA Transition Strategy?
yes
2.a. If yes, provide the investment name as identified in the Transition Strategy provided in the agency's most recent annual EA Assessment.
CDC PHIN: BioSense
3. Is this investment identified in a completed (contains a target architecture) and approved segment architecture?
yes
3.a. If yes, provide the name of the segment architecture as provided in the agency’s most recent annual EA Assessment.
Public Health Information Network
4. Identify the service components funded by this major IT investment (e.g., knowledge management, content management, customer relationship management, etc.). Provide this information in the format of the following table. For detailed guidance regarding components, please refer to http://www.whitehouse.gov/omb/egov/.

Component: Use existing SRM Components or identify as NEW. A NEW component is one not already identified as a service component in the FEA SRM.

Reused Name and UPI: A reused component is one being funded by another investment, but being used by this investment. Rather than answer yes or no, identify the reused service component funded by the other investment and identify the other investment using the Unique Project Identifier (UPI) code from the OMB Ex 300 or Ex 53 submission.

Internal or External Reuse?: Internal reuse is within an agency. For example, one agency within a department is reusing a service component provided by another agency within the same department. External reuse is one agency within a department reusing a service component provided by another agency in another department. A good example of this is an E-Gov initiative service being reused by multiple organizations across the federal government.

Funding Percentage: Please provide the percentage of the BY requested funding amount used for each service component listed in the table. If external, provide the funding level transferred to another agency to pay for the service.
RowAgency Component NameAgency Component DescriptionService TypeComponentReused Component NameReused UPIInternal or External Reuse?Funding %
1Standardized / CannedDefines the set of capabilities that support the use of pre-conceived or pre-written reports.ReportingStandardized / Canned  No Reuse10
2Ad HocDefines the set of capabilities that support the use of dynamic reports on an as needed basis.ReportingAd Hoc  No Reuse5
3MathematicalDefines the set of capabilities that support the formulation and mathematical analysis of probabilistic models for random phenomena and the development and investigation of methods and principles for statistical inference.Analysis and StatisticsMathematical  No Reuse15
4ModelingDefines the set of capabilities that develop descriptions to adequately explain relevant data for the purpose of prediction, pattern detection, exploration or general organization of data.Knowledge DiscoveryModeling  No Reuse15
5Data MiningDefines the set of capabilities that provide for the efficient discovery of non-obvious, valuable patterns and relationships within a large collection of data.Knowledge DiscoveryData Mining  No Reuse30
5. To demonstrate how this major IT investment aligns with the FEA Technical Reference Model (TRM), please list the Service Areas, Categories, Standards, and Service Specifications supporting this IT investment.

FEA SRM Component: Service Components identified in the previous question should be entered in this column. Please enter multiple rows for FEA SRM Components supported by multiple TRM Service Specifications.

Service Specification: In the Service Specification field, Agencies should provide information on the specified technical standard or vendor product mapped to the FEA TRM Service Standard, including model or version numbers, as appropriate.
RowSRM Component>Service AreaService CategoryService StandardService Specification (i.e., vendor and product name)
1Standardized / CannedComponent FrameworkData InterchangeData ExchangeElectronic Business using XML
2Ad HocComponent FrameworkData InterchangeData ExchangeElectronic Business using XML
3MathematicalComponent FrameworkData InterchangeData ExchangeElectronic Business using XML
4ModelingComponent FrameworkData InterchangeData ExchangeElectronic Business using XML
5Data MiningComponent FrameworkData InterchangeData ExchangeElectronic Business using XML
6Standardized / CannedService Interface and IntegrationInteroperabilityData Format / ClassificationHealth Level 7 (HL7)
7Ad HocService Interface and IntegrationInteroperabilityData Format / ClassificationHealth Level 7 (HL7)
8MathematicalService Interface and IntegrationInteroperabilityData Format / ClassificationHealth Level 7 (HL7)
9ModelingService Interface and IntegrationInteroperabilityData Format / ClassificationHealth Level 7 (HL7)
10Data MiningService Interface and IntegrationInteroperabilityData Format / ClassificationHealth Level 7 (HL7)
11Standardized / CannedService Interface and IntegrationInteroperabilityData Format / ClassificationHITSP
12Ad HocService Interface and IntegrationInteroperabilityData Format / ClassificationHITSP
13MathematicalService Interface and IntegrationInteroperabilityData Format / ClassificationHITSP
14ModelingService Interface and IntegrationInteroperabilityData Format / ClassificationHITSP
15Data MiningService Interface and IntegrationInteroperabilityData Format / ClassificationHITSP
16Standardized / CannedService Interface and IntegrationInteroperabilityData TransformationInformatica
17Ad HocService Interface and IntegrationInteroperabilityData TransformationInformatica
18MathematicalService Interface and IntegrationInteroperabilityData TransformationInformatica
19ModelingService Interface and IntegrationInteroperabilityData TransformationInformatica
20Data MiningService Interface and IntegrationInteroperabilityData TransformationInformatica
21Standardized / CannedService Interface and IntegrationInteroperabilityData Format / ClassificationInternational Classification of Diseases
22Ad HocService Interface and IntegrationInteroperabilityData Format / ClassificationInternational Classification of Diseases
23MathematicalService Interface and IntegrationInteroperabilityData Format / ClassificationInternational Classification of Diseases
24ModelingService Interface and IntegrationInteroperabilityData Format / ClassificationInternational Classification of Diseases
25Data MiningService Interface and IntegrationInteroperabilityData Format / ClassificationInternational Classification of Diseases
26Standardized / CannedService Interface and IntegrationInteroperabilityData Format / ClassificationLogical Observation Identifier Names and Codes
27Ad HocService Interface and IntegrationInteroperabilityData Format / ClassificationLogical Observation Identifier Names and Codes
28MathematicalService Interface and IntegrationInteroperabilityData Format / ClassificationLogical Observation Identifier Names and Codes
29ModelingService Interface and IntegrationInteroperabilityData Format / ClassificationLogical Observation Identifier Names and Codes
30Data MiningService Interface and IntegrationInteroperabilityData Format / ClassificationLogical Observation Identifier Names and Codes
31Standardized / CannedService Platform and InfrastructureHardware / InfrastructureWide Area Network (WAN)SONET, Bellsouth
32Ad HocService Platform and InfrastructureHardware / InfrastructureWide Area Network (WAN)SONET, Bellsouth
33MathematicalService Platform and InfrastructureHardware / InfrastructureWide Area Network (WAN)SONET, Bellsouth
34ModelingService Platform and InfrastructureHardware / InfrastructureWide Area Network (WAN)SONET, Bellsouth
35Data MiningService Platform and InfrastructureHardware / InfrastructureWide Area Network (WAN)SONET, Bellsouth
36Standardized / CannedService Interface and IntegrationInteroperabilityData Format / ClassificationSystematized Nomenclature of Medicine Clinical Terms (SNOMED CT)
37Ad HocService Interface and IntegrationInteroperabilityData Format / ClassificationSystematized Nomenclature of Medicine Clinical Terms (SNOMED CT)
38MathematicalService Interface and IntegrationInteroperabilityData Format / ClassificationSystematized Nomenclature of Medicine Clinical Terms (SNOMED CT)
39ModelingService Interface and IntegrationInteroperabilityData Format / ClassificationSystematized Nomenclature of Medicine Clinical Terms (SNOMED CT)
40Data MiningService Interface and IntegrationInteroperabilityData Format / ClassificationSystematized Nomenclature of Medicine Clinical Terms (SNOMED CT)
41Standardized / CannedService Access and DeliveryService TransportSupporting Network ServicesT1
42Ad HocService Access and DeliveryService TransportSupporting Network ServicesT1
43MathematicalService Access and DeliveryService TransportSupporting Network ServicesT1
44ModelingService Access and DeliveryService TransportSupporting Network ServicesT1
45Data MiningService Access and DeliveryService TransportSupporting Network ServicesT1
46Standardized / CannedService Access and DeliveryService TransportSupporting Network ServicesT3
47Ad HocService Access and DeliveryService TransportSupporting Network ServicesT3
48MathematicalService Access and DeliveryService TransportSupporting Network ServicesT3
49ModelingService Access and DeliveryService TransportSupporting Network ServicesT3
50Data MiningService Access and DeliveryService TransportSupporting Network ServicesT3
51Standardized / CannedComponent FrameworkSecurityCertificates / Digital SignaturesVeriSign
52Ad HocComponent FrameworkSecurityCertificates / Digital SignaturesVeriSign
53MathematicalComponent FrameworkSecurityCertificates / Digital SignaturesVeriSign
54ModelingComponent FrameworkSecurityCertificates / Digital SignaturesVeriSign
55Data MiningComponent FrameworkSecurityCertificates / Digital SignaturesVeriSign
56Standardized / CannedService Access and DeliveryAccess ChannelsWeb BrowserWindows Internet Explorer 6.0
57Ad HocService Access and DeliveryAccess ChannelsWeb BrowserWindows Internet Explorer 6.0
58MathematicalService Access and DeliveryAccess ChannelsWeb BrowserWindows Internet Explorer 6.0
59ModelingService Access and DeliveryAccess ChannelsWeb BrowserWindows Internet Explorer 6.0
60Data MiningService Access and DeliveryAccess ChannelsWeb BrowserWindows Internet Explorer 6.0
6. Will the application leverage existing components and/or applications across the Government (i.e., FirstGov, Pay.Gov, etc)?
yes
6.a. If yes, please describe.
This investment leverages: Federal Health Architecture (FHA)

PART TWO


RISK


You should perform a risk assessment during the early planning and initial concept phase of the investment's life-cycle, develop a risk-adjusted life-cycle cost estimate and a plan to eliminate, mitigate or manage risk, and be actively managing risk throughout the investment's life-cycle.

Answer the following questions to describe how you are managing investment risks.
1. Does the investment have a Risk Management Plan?
yes
1.a. If yes, what is the date of the plan?
2007-07-23
1.b. Has the Risk Management Plan been significantly changed since last year's submission to OMB?
yes
1.c. If yes, describe any significant changes:
BioSense underwent an Independent Verification and Validation (IV&V) assessment in order to ensure the chosen architecture and implementation approach is in alignment with industry best practices. This assessment began in May 2006 with the intent to do a thorough review of all aspects of the BioSense technical architecture, platform and operations. The study provided strengths and weaknesses as well recommendations to CDC on refining the vision, establishing goals, outcomes and performance metrics for BioSense. As a result of the IV&V, an updated risk management plan was implemented in September 2006.
3. Briefly describe how investment risks are reflected in the life cycle cost estimate and investment schedule:
The BioSense scope and budget planning using a work breakdown structure technique that decomposes each work element into its fundamental components. Each component is evaluated based on a risk assessment and the appropriate level of funding is assigned based on the work element's risk value. The budget for each element is derived based on the most likely scenario that has been risk adjusted. The total of each element comprises the full budget for BioSense. BioSense reviews its risks on a weekly basis and evaluates any potential changes to the budget plan.

COST & SCHEDULE


1. Does the earned value management system meet the criteria in ANSI/EIA Standard 748?
yes
2. Is the CV% or SV% greater than ± 10%?
no
3. Has the investment re-baselined during the past fiscal year?
no